Demeng Chen
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Urology top 1%
- Hair Growth and Disorders
Papers in
- Oncology 17
- Cancer Cells and Metastasis 10
- Cancer Immunotherapy and Biomarkers 9
-
- RNA modifications and cancer 14
- Ubiquitin and proteasome pathways 3
- Co-authors
- Radhika P. Atit (3 shared papers)Cun‐Yu Wang (4 shared papers)Maosheng Cheng (13 shared papers)Andrew S Jarrell (1 shared paper)Richard A. Lang (1 shared paper)Rui‐Hua Xu (1 shared paper)Feng Wang (1 shared paper)Tiebang Kang (1 shared paper)
- Journals
- International Journal of Oral Science (5 papers)Journal of Clinical Investigation (3 papers)Molecular Therapy (3 papers)Nature Communications (3 papers)Oral Diseases (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Demeng Chen
70 papers receiving 3.6k citations
Demeng Chen's Hit Papers
Peers
Comparison fields: 5 of 98
- Otorhinolaryngology 178
- Urology 221
- Molecular Biology 1.9k
- Cancer Research 310
- Oncology 495
Countries citing papers authored by Demeng Chen
This map shows the geographic impact of Demeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demeng Chen more than expected).
Fields of papers citing papers by Demeng Chen
This network shows the impact of papers produced by Demeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Demeng Chen. The network helps show where Demeng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Demeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma Hit paper breakdown → | 2019 | 639 |
| 2 | 2017 | 240 | |
| 3 | 2012 | 207 | |
| 4 | 2017 | 171 | |
| 5 | 2022 | 161 | |
| 6 | 2019 | 159 | |
| 7 | 2020 | 130 | |
| 8 | 2014 | 119 | |
| 9 | 2018 | 113 | |
| 10 | 2021 | 112 | |
| 11 | 2016 | 83 | |
| 12 | 2018 | 83 | |
| 13 | 2021 | 81 | |
| 14 | 2021 | 80 | |
| 15 | 2019 | 79 | |
| 16 | 2019 | 76 | |
| 17 | 2021 | 73 | |
| 18 | 2009 | 65 | |
| 19 | 2021 | 56 | |
| 20 | 2021 | 48 |
About Demeng Chen
Demeng Chen is a scholar working on Oncology, Molecular Biology, Otorhinolaryngology, Oral Surgery and Urology, having authored 72 papers that have together received 3.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (14 papers), Cancer Cells and Metastasis (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Head and Neck Cancer Studies (5 papers), Hair Growth and Disorders (4 papers), Ubiquitin and proteasome pathways (3 papers), Oral and Maxillofacial Pathology (3 papers) and Mesenchymal stem cell research (3 papers). The work is most often cited by research in Otorhinolaryngology (178 citations), Urology (221 citations), Molecular Biology (1.9k citations), Cancer Research (310 citations) and Oncology (495 citations). Demeng Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Radhika P. Atit, Cun‐Yu Wang, Maosheng Cheng, Andrew S Jarrell, Richard A. Lang, Rui‐Hua Xu, Feng Wang, Tiebang Kang, Xingyang Li and Huai‐Qiang Ju. Their work appears in journals such as International Journal of Oral Science, Journal of Clinical Investigation, Molecular Therapy, Nature Communications and Oral Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.